FIG. 4.
Mean plasma concentration-versus-time profiles of acyclovir in treatment group B (n = 5; 500 mg of valacyclovir [VCV] at PK 1 and 500 mg of VCV plus 500 mg of cephalexin [CPX] at PK 2). Standard deviations are shown as error bars.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.